학술논문
Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial
Document Type
Article
Author
Maher, T.M.; Tudor, V.A.; Renzoni, E.A.; Kokosi, M.; Wells, A.U.; Molyneaux, P.L.; Ashby, D.; Szigeti, M.; Saunders, P.; Hoyles, R.K.; Gibbons, M.A.; Fletcher, S.V.; Denton, C.P.; Parfrey, H.; Akil, M.; Babalis, D.; Chaudhuri, N.; Chua, F.; Data, A.; Desai, D.; Dubey, S.; Dwyer, N.; Flather, M.; Fordham, R.; Grossi Sampedro, C.; Hall, F.; Jakupovic, I.; Keir, G.; Patel, B.; Penn, H.; Rajasekaran, A.; Spencer, L.G.; Tsipouri, V.; Wu, Z.; Xydopoulos, G.; Zanghelini, F.
Source
In: The Lancet Respiratory Medicine . (The Lancet Respiratory Medicine, January 2023, 11(1):45-54)
Subject
Language
English
ISSN
22132619
22132600
22132600